Genmab
GMAB
GMAB
225 hedge funds and large institutions have $1.51B invested in Genmab in 2023 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 54 increasing their positions, 103 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
225
Holders Change
-8
Holders Change %
-3.43%
% of All Funds
3.3%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
43
Increased
54
Reduced
103
Closed
46
Calls
$996K
Puts
$178K
Net Calls
+$818K
Net Calls Change
+$1.28M
Top Buyers
| 1 |
1
AllianceBernstein
Nashville,
Tennessee
|
$497M |
| 2 |
2
Morgan Stanley
New York
|
$69.4M |
| 3 |
3
Millennium Management
New York
|
$16.3M |
| 4 |
4
Renaissance Technologies
New York
|
$47.6M |
| 5 |
AP
5
Antipodes Partners
Royal Exchange,
Australia
|
$5.91M |
